Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for diagnosing and monitoring schizophrenia and tauopathies

Method for diagnosing and monitoring schizophrenia and tauopathies

US Patent 9518994 · Granted Dec 13, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Neuroprotective peptides derived from activity-dependent neuroprotective protein2021
Method for identifying a modulator of cell survival or plasticity2020
Compounds and methods for inhibiting cell death2018
Use of ADNF polypeptides for treating anxiety and depression2013
NAP alpha-aminoisobutyric acid analog with neuroprotective activity2013
Therapeutics based on tau/microtubule dynamics2013
Neuroprotection using NAP-like and SAL-like peptide mimetics2012
Use of ADNF polypeptides for treating peripheral neurotoxicity2012
Protection of the retina against laser injury by NAP and related peptides2011
Orally active peptides that prevent cell damage and death2011
Use of ADNF III polypeptides for treating mental diseases and disorders, includi2011
Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypepti2011